MedPath

Trait Anxiety and Defensive Networks

Not Applicable
Completed
Conditions
Healthy
Interventions
Behavioral: trait anxiety scale
Drug: Placebo
Registration Number
NCT02682888
Lead Sponsor
University of Electronic Science and Technology of China
Brief Summary

to examine the association between trait and defensive network connectivity and the modulatory effect of oxytocin on it

Detailed Description

Individuals with high trait anxiety show stable anxiety proneness even in the absence of real threat, which could be a result of intrinsic hyper-connectivity in the defensive systems. In the present study, healthy subjects' trait anxiety levels will be assessed by the sub-trait inventory of the State-Trait Anxiety Inventory. Then two experiments using resting-state fMRI technique will be conducted to first map how hubs in the defensive systems organized in high anxious individuals in a stimuli-free situation (Experiment 1) and then we will examine the modulatory effect of the intranasal administration of oxytocin on functional connectivity in these independently defined defensive networks (Experiment 2).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
131
Inclusion Criteria
  • Healthy subjects without past or current psychiatric or neurological disorders
Exclusion Criteria
  • females should not be pregnant or during menstruation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
high trait anxiety grouptrait anxiety scaleexperiment 1: identified according to scores of the trait anxiety scale.
placebo control groupPlaceboexperiment 2: intranasal administration of placebo
low trait anxiety grouptrait anxiety scaleexperiment 1: identified according to scores of the trait anxiety scale.
oxytocin groupOxytocinexperiment 2: intranasal administration of oxytocin
Primary Outcome Measures
NameTimeMethod
the resting state functional connectivity changes in the defensive networkone day

The resting-state activity can be accessed using functional magnetic resonance imaging (fMRI) by measuring spontaneous and low-frequency fluctuations (\< 0.1 Hz) when the brain is at rest. Group differences will be calculated in the high trait anxiety group relative to the low trait anxiety group and in the oxytocin group relative to the placebo group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

school of life science and technology, University of Electronic Science and Technology of China

🇨🇳

Chengdu, Sichuan, China

school of life science and technology, University of Electronic Science and Technology of China
🇨🇳Chengdu, Sichuan, China
© Copyright 2025. All Rights Reserved by MedPath